Podcast Episodes
Back to Search
253: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers
Our colleague Matthew Herper joins us for a deep dive into Illumina, explaining how the biggest company in genome sequencing lost the faith of shareh…
3 years, 6 months ago
252: Biotech's monkey shortage, the broken generics market, & conference cancel culture
We explain how biotech is affected by a bizarre situation involving smuggled monkeys, international intrigue, and a criminal investigation. We also d…
3 years, 7 months ago
251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster
We discuss the theatrical merits and actual implications of Moderna CEO Stéphane Bancel's appearance before a committee led by Sen. Bernie Sanders. W…
3 years, 7 months ago
250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina
STAT reporter Bob Herman joins us to explain how treatment algorithms powered by artificial intelligence are being used more frequently by Medicare A…
3 years, 7 months ago
249: Robert Califf on how drugs get approved, plus the nascent revolution in obesity
FDA Commissioner Robert Califf joins to discuss his first year on the job, the future of drug approvals, and how Duke basketball will do without Coac…
3 years, 7 months ago
248: The next CRISPR fight, cheaper insulin, & an FDA shuffle
Our colleague Allison DeAngelis joins us to explain how the latest CRISPR breakthrough is shaping up to be a free-for-all among a multitude of compan…
3 years, 7 months ago
247: Vertex vs. insurers, Moderna's future, & biotech's long winter
STAT’s Ed Silverman joins us to explain how an escalating fight between Vertex Pharmaceuticals and insurance companies has left patients and families…
3 years, 8 months ago
246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid
Vas Narasimhan, CEO of Novartis and the new chairman of PhRMA, joins us to discuss the industry’s struggles in Washington and whether the deflated bi…
3 years, 8 months ago
245: The return of bird flu and the effects of pandemic fatigue
Helen Branswell, STAT’s senior writer covering infectious disease, joins us to explain the sudden resurgence of a bird flu virus called H5N1 and why …
3 years, 8 months ago
244: Pharma blockbusters, pandemic policy, & legal chicanery
STAT Washington correspondent Rachel Cohrs joins us to explain the looming end of Covid-19's status as a federal emergency and what that does and doe…
3 years, 8 months ago